Injectable microspheres may provide a means of providing local, sustained exposure of glioma to chemotherapeutics to improve patient survival. Using a rodent model of surgically resected glioma, we previously demonstrated that direct injections of chemotherapeutic microspheres into the tissue surrounding a resection cavity provide superior survival effects over injections of the same microspheres directly into the surgical cavity. The present experiments extended this novel observation by exploring several parameters related to the use of intraparenchymal injections of chemotherapeutic microspheres to treat glioma. Using a rat model of resected glioma, several principles regarding the use of local sustained release carboplatin microspheres were established. First, an inverted U dose-response was observed, wherein further dose escalation beyond the optimal dose was not efficacious and indeed produced significant local toxicity. Second, it was necessary to expose approximately 40% of the tumor margin to sustained release carboplatin in order to increase survival in this model. Survival was not enhanced when the proportion of the tumor margin exposed to carboplatin was only 20%. Third, the distribution of the chemotherapeutic microsphere injections along the tumor perimeter was shown to be important, requiring that the entire perimeter be proportionately exposed to the chemotherapeutic agent. Together, these data continue to support the development of chemotherapeutic microspheres for treating glioma. However, they also caution that a number of fundamental parameters can profoundly influence the efficacy that might be expected from local sustained delivery. Careful attention to these principles is not only required if chemotherapeutic microspheres are to be used efficaciously, but these principles should provide a foundation to further optimize the potential of this and other polymeric delivery systems under development for local, intraparenchymal drug delivery to glioma.
INTRODUCTION
lease 1,3-bis[2-chloroethyl]-1-nitrourea (BCNU) (4,5, 11, 25) . Following surgical resection of tumors, the polymer disks are placed into the resulting cavity where the Malignant gliomas are resistant to treatment. Even with the use of aggressive treatment regimens that include BCNU is released and diffuses into the surrounding tissue and residual tumor mass. Using this approach, statis-combinations of surgery, radiation therapy, and systemic chemotherapy, the median survival of patients remains tically significant patient benefit has been observed, with median survival increased by 8 weeks (5). FDA approximately 1 year from the time of diagnosis, while cases of long-term disease-free survival in adults are approval was recently granted for BCNU-loaded polymer disks as an adjunctive treatment to surgically re-rare (1) .
Injectable, biodegradable polymers are being investi-sected recurrent glioma. Despite the promise of using BCNU-loaded wafers gated as a means of providing sustained and improved local exposure of glioma to chemotherapeutics to enhance to improve postsurgical survival, tumor recurrence still occurs quite rapidly. This is likely because the diffusion survival. Polymers containing various chemotherapeutics have been evaluated in animal models of brain tu-of BCNU into the surrounding tissue is limited, leaving regions of local tumor infiltration with insufficient drug mors (3, 10, 11, 14, 17, 19, 22, 24) and used most recently in the treatment of human glioma (4,5,15). The most suc-exposure (15, 16, 21) . If higher concentrations could be delivered directly to the area where tumor recurrence is cessful approach, to date, uses poly[bis( p-carboxyphemoxy)]propane-sebacic acid copolymer disks that re-most likely (i.e., the tissue within several centimeters of the surgical cavity), greater efficacy might be achieved In the meantime, however, insight might be gained into the resolution of several practical issues before con- (12) .
One way of increasing the likelihood that cytotoxic sideration of intraparenchymal injections of chemotherapeutic microspheres for widespread clinical evaluation. levels of a chemotherapeutic drug reach the more distal regions of tumor infiltration is to implant drug-loaded To begin to develop an understanding of the principles necessary for successful implementation of intraparen-polymers directly into these sites. Unfortunately, it is impractical to implant monolithic devices such as poly-chymal sustained release chemotherapy, the following studies used chemotherapeutic microspheres to system-mer disks directly into tissue where tumor regrowth is most likely to occur. The size of the disks limits their atically evaluate a number of potentially important issues. Using sustained release carboplatin as a prototypic use to situations where the tumor is surgically accessible. Thus, delivery of chemotherapeutic agents to areas chemotherapeutic, these studies sought to answer several questions regarding the use of injectable microspheres of tumor infiltration can only be achieved by the limited diffusion that occurs from the surgical cavity and not in for local delivery of chemotherapeutic agents to increase survival from glioma. These included the effect of the many areas of the brain with a high probability of tumor recurrence. An attractive alternative that would permit dose of sustained release carboplatin, the proportion of the tumor margin that requires exposure to the chemo-delivery directly to the sites of residual tumor and tumor recurrence is provided by the use of polymers such as therapeutic, and the effect of the distribution of microsphere injections around the tumor margin. The re-poly(L-lactide)co-glycolide (PLG) composed of small diameter, injectable microspheres (<100 µm). Micro-sults of these studies not only continue to support the potential use of chemotherapeutic microspheres for spheres can be formulated to provide excellent in vivo release kinetics, delivering high local concentrations of treating glioma, but they also provide a foundation for additional experiments aimed at maximizing the thera-drugs for predefined, sustained periods of time, ranging from days to months. Microspheres have been proven peutic effects. to be efficient systems for delivery of a wide range of MATERIALS AND METHODS chemotherapeutic drugs and can be easily injected as a Subjects suspension allowing drug delivery into virtually any site of the brain with minimal invasiveness (2,6-8, 13, 17, 18) .
Male Fischer rats (N = 378; 200-220 g; Taconic Using a rodent model of surgically resected glioma, Farms, Germantown, NY) were used in all studies. The we previously demonstrated that direct injections of mirats were housed in pairs in polypropylene cages with crospheres containing either carboplatin or BCNU into free access to food and water. The vivarium was mainthe tissue surrounding a surgical resection cavity provide tained on a 12-h light/12-h dark cycle with a room temsuperior survival effects over injections of the same miperature of 22 ± 1°C and relative humidity level of 50 ± crospheres directly into the surgical cavity (7). The re-5%. All studies were approved in advance by Alkermes sults provided the first direct evidence for the superiority Institutional Animal Care and Use Committee and were of peritumoral injections as a means of local chemotherconducted in compliance with the rules set forth in the apy. If confirmed in human glioma patients, this approach Guide for the Care and Use of Laboratory Animals. could positively impact the future use of polymeric de-Fabrication of Carboplatin-Loaded Microspheres livery systems for treating brain tumors. Interestingly, Menei and colleagues recently reported the results of a
The carboplatin-loaded microspheres used in these studies were the same as those previously described and preliminary uncontrolled clinical study in which 5-FUloaded microspheres were injected into the cavity wall provided a sustained delivery of carboplatin for approximately 2-3 weeks (7,8,10). Briefly, microspheres (PLG, produced by surgical resection of glioma in eight patients (18) . The procedure was well tolerated and, at the Microsorb 50/50 DL, MW = 10 kDa, Alkermes Inc., Wilmington, OH) were fabricated to provide a carbo-time of the report, median survival was 98 weeks, with one patient in remission at 153 weeks posttreatment.
platin (Sigma Chemical) loading density of 10% (w/w) using a coacervation process. Initially, 1.0 g of PLG was These impressive results suggest that polymeric delivery of chemotherapeutic drugs directly into the tissue sur-dissolved in 10 ml of methylene chloride. Ground/sieved carboplatin (110 mg) (<5 µm diameter) was added to rounding the resection cavity may provide a practical and more effective means of treating glioma over that this solution and sonicated for 5 min followed by vigorous vortexing. Nine milliliters of poly(dimethylsiloxane) normally expected with delivery into the resection cavity. Future studies will certainly require larger cohorts (Aldrich, 350 cst) was then added and the resulting emulsion was mixed and stirred with 1 L of heptane for 2 h. and direct comparisons between groups receiving systemic therapy, as well as sustained release directly into The microspheres were collected by filtration and the solvent was allowed to evaporate. The microspheres the surgical cavity, before these preliminary data can be safely interpreted.
were then washed twice with 0.8% Triton X-100, sus-pended in a 1% polyvinyl acetate (PVA) solution, and to one of several treatment groups (N = 15/group): no resection/no treatment, surgical resection only, surgical sieved through 70-and 40-µM cell strainers. All microspheres were washed with distilled water prior to being resection plus sustained release carboplatin (25, 50, 100, or 200 µg/site) injected into four sites along the perime-frozen at −70°C and lyophilized under 50 µTorr for 2 days. Blank (nonloaded) microspheres were treated in ter of the cavity, or surgical resection plus sustained release carboplatin (25, 50, 100, or 200 µg/site) injected an identical manner except that carboplatin was omitted from the procedure.
into eight sites along the perimeter of the cavity. The microspheres were injected either 2 mm (eight sites) or Tumor Cell Implantation 4 mm (four sites) apart from the adjacent sites. Rat glioma (RG2) cells were maintained and pre-Relationship Between the Spatial Distribution pared for implantation as previously described. Rats of Carboplatin Microsphere Injections and Survival were anesthetized with an intramuscular injection of ketamine (33 mg/ml), xylazine (10 mg/ml), and aceproma-In some cases, injecting chemotherapeutic microspheres completely around the tumor margin of resected zine (1.6 mg/ml) and placed in a stereotaxic instrument. Using a 10-µl Hamilton syringe and a 22-gauge needle, glioma may not be advisable because some portions of the tumor are inaccessible or extend into regions were cells (5 × 10 4 cells/2 µl) were injected unilaterally into the cortex at the following coordinates: A-P (−1.0 mm), injection is not advisable. In either case, a decision will need to be made about how to spatially distribute the L (+4.0 mm), and V (−2.5 mm) (20).
implants along the tumor margin. For this reason, 90 Tumor Resection and Microsphere Implantation animals were used to explore the impact of the distribution of carboplatin-loaded microspheres on survival by Two variations of the tumor resection model were employed, which differed only in how long the tumor determining if implants into only one side of the tumor margin were as efficacious as implants that delivered was allowed to grow prior to resection. Either 10 or 14 days following implantation of RG2 tumor cells, anes-the same total amount of carboplatin and were equally distributed around the entire tumor margin. Animals re-thetized animals were placed into a stereotaxic device and a craniotomy was made extending 2-4 mm radially ceived cortical implants of RG2 cells followed by debulking of the tumor 14 days later and were assigned from the original burr hole. The dura was excised and a hand-held aspirative device was used to grossly resect to one of several treatment groups (N = 15/group): no resection/no treatment, surgical resection only, surgical the tumor from the cavity, leaving behind a small margin-positive resection area (approximately 10% of the resection plus sustained release carboplatin microspheres injected into four sites along one side of the perimeter original tumor mass) to evaluate the effects of the drugloaded microspheres on regrowth of the tumor and sur-of the cavity (injections made 2 mm apart), surgical resection plus sustained release microspheres injected into vival of the animals. For implantation, the microspheres were suspended in a solution of 0.9% saline, 0.1% Tween, four sites along both sides of the perimeter of the cavity (injections made 4 mm apart), surgical resection plus and 3.0% carboxymethylcellulose (low viscosity). The microsphere suspension (10 µl) was injected at a rate of sustained release microspheres injected into eight sites along one side of the perimeter of the cavity (injections 2 µl/min using a 10-µl Hamilton syringe with an attached 23-gauge needle. In all cases, the microspheres were in-made 1 mm apart), or surgical resection plus sustained release microspheres injected into eight sites along both jected approximately 1.0 mm from the edge of the resection cavity. Identical amounts of microspheres were im-sides of the perimeter of the cavity (injections made 2 mm apart). In all cases, the dose of sustained release planted in all cases by adding blank microspheres to the suspension. Animals were monitored daily, and any ani-carboplatin was 25 µg/site. This dose was based on the previous dose-response curve data demonstrating that mal showing signs of morbidity was euthanized and that date recorded for calculating survival data.
this amount of sustained release carboplatin produced a robust and reliable increase in survival beyond that
Studies Varying Dose and Density achieved with surgery alone. of Carboplatin Microspheres
Relationship Between Diffusion of Carboplatin One hundred and fifty animals were used to explore From Microspheres and Survival the efficacy produced by a wide range of sustained release carboplatin doses following tumor resection. These A series of animals was used to determine the proportion of the tumor margin that requires exposure to sus-experiments varied the total amount of carboplatin per injection site as well as the numbers of injection sites tained release carboplatin to enhance survival. Animals received RG2 implants followed by surgical resection along the perimeter of the resection cavity. Animals received cortical implants of RG2 cells followed by de-either 10 or 14 days later. Immediately following surgery, one set of animals from each group (N = 6/group) bulking of the tumor 14 days later and were assigned 38 EMERICH, WINN, AND BARTUS was sacrificed. The brains were removed and cut coro-the striatum was processed for the immunocytochemical localization of neurons using the neuron-specific marker nally at 20-µm intervals on a cryostat (−16°C) throughout the length of the resection cavity and the sections NeuN (1:300) as follows: 1) slides washed 6 × 10 min in dilution media (Triton X and TRIS buffer) followed were stained for hemotoxylin and eosin (H&E). The volume of the cavity produced by surgical resection was by 0.1 M sodium periodate for 1 h, 2) slides washed 3 × 10 min in dilution media, followed by incubation in nor-then calculated as previously described. Two other sets of animals received RG2 implants and surgical resection mal horse serum and bovine serum albumin for 1 h, 3) slides incubated for 48 h (24 h at 22°C and 24 h at 4°C) 10 or 14 days later. Immediately following surgery, animals received implants of carboplatin-loaded microspheres in the primary monoclonal antibody (1:100), 4) slides washed 6 × 10 min in dilution media followed by a 1-h (25 µg/site) into either four (10-day resection only) or eight (both 10-and 14-day resection) separate sites as incubation in biotinylated secondary IgG antibody (1:200; Vector, Burlingame, CA), 5) slides washed 6 × 10 min described above. One series of animals was used for survival studies (N = 15/group). The other series (N = 6/ in dilution media-rinsed slides, 6) slides incubated with "Elite" avidin-biotin complex (1:1000; Vector) for 1.25 group) was sacrificed 3 days later and brain sections were stained with H&E to calculate the volume of the h, 7) slides rinsed 3 × 10 min in imidazole/acetate buffer, 8) slides incubated in a solution containing 3,3′ diamino-microspheres following implantation into the brain, as previously described (7). This 3-day time point was cho-benzidine and nickel ammonium sulfate dissolved in imidazole/acetate buffer with hydrogen peroxide for 8 min, sen to allow the brain tissue to heal and facilitate the ability to retain the microspheres within the tissue dur-and 9) reaction terminated by rinsing 3 × 10 min in imidazole/acetate buffer. Sections were stored in PBS, ing sectioning. Using the volumes for the resection cavities, the volume of tissue in a 2-mm strip around the mounted, dehydrated in alcohol, and cover slipped. Control sections were processed in an identical manner ex-tumor margin was determined. This region was chosen based on previous calculations showing that carboplatin cept the primary antibody solvent was substituted for the primary antibody. diffused only 0.5 mm from the implant site. Because the micropshere injections were made 1 mm from the edge Three sequential sections centered on the injection tract were used for quantification of cell numbers fol-of the resection cavity, the 2-mm strip of surrounding tissue completely encompassed the area of carboplatin lowing injections of carboplatin-loaded microspheres. All cell counts were performed at a magnification of diffusion from the microspheres. Using this volumetric data, the total volume of tissue that was exposed to sus-40× in an area extending from the corpus callosum ventrally to the anterior commissure and laterally in each tained release carboplatin was determined within the 2mm rim of tissue surrounding the resection cavity. direction 1 mm from the injection tract. For comparisons, cell counts were performed in the identical region Immunocytochemistry within the contralateral, noninjected striatum. Within each section, all positive cells were counted and the total A separate study was conducted in normal animals using NeuN immunocytochemistry to determine the po-number of neurons on each side was computed and used for analysis. tential neuronal toxicity of sustained release carboplatin. Animals received a single intrastriatal injection of car-Statistical Analysis boplatin microspheres releasing a total of 25, 100, or Survival after each treatment was analyzed using 200 µg carboplatin (N = 6 group). The following coordi-Kaplan-Meier survival curves. Nonparametric Kruskalnates were used for all implantation sites: 0.5 mm ante-Wallis statistics were used to determine overall treatrior to bregma, 3.0 mm lateral to the sagittal suture, and ment effects using the day of death as the nonparametric 5.5 mm below the cortical surface. To provide an intervariable (JMP, SAS Institute Inc., Cary, NC). The nonnal control for cell counts, an equal amount of blank parametric modification of the Newman-Keuls test was microspheres was injected into the contralateral striatum used for subsequent pairwise comparisons. The effects using the same coordinates. Three weeks later (a time of carboplatin-loaded microsphere injections on neupoint when the carboplatin had been completely released ronal cell counts were compared using a one-way analyfrom the microspheres) animals were transcardially persis of variance. Statistical significance in all cases was fused under deep anesthesia using a peristaltic pump defined as p < 0.05 with 20 ml saline followed by 500 ml of 4% Zamboni's fixative. All solutions were ice cold (4°C) and prepared RESULTS in 50 mM PBS (pH 7.4). Brains were removed following Effects of Dose and Density fixation, placed in 25% buffered sucrose (pH 7.4), and of Carboplatin Microspheres refrigerated for approximately 48 h. Sections were cut at 40-µm intervals on a sliding microtome and stored in The cortical RG2 tumor was uniformly fatal to all nontreated animals, with a median survival of 19 days a cryoprotectant solution. Every sixth section through and maximum survival of 23 days posttumor implanta-Surgical resection of the 10-day-old glioma eliminated most of the tumor mass and resulted in a cavity tion ( Fig. 1 and Table 1 ). Surgical resection alone significantly increased median survival by 10 days (53%) rel-with a mean volume of 16.08 ± 1.99 mm 3 (Table 2) . Volumetric calculations further determined that the vol-ative to untreated animals, with all animals dying by 35 days postimplantation (increase of 52%, p < 0.01). Injec-ume of tissue exposed to carboplatin was 9.02 mm 3 per site. Accordingly, four separate microsphere injections tion of carboplatin-loaded microspheres into four sites, each separated by 4 mm from the adjacent sites, along along the 10-day-old resection cavity occupied approximately 44% of the 2-mm rim of tissue along the cavity. the cavity did not impact survival ( ps > 0.10), independent of the dose of carboplatin delivered, beyond that As shown in Figure 3 , parallel survival studies demonstrated that carboplatin microspheres injected into four achieved with surgery alone (Fig. 1a) . In contrast, injection of microspheres into eight sites, each separated by sites (each separated by 2 mm) within the tumor margin significantly prolonged survival relative to surgery alone 2 mm from the adjacent sites, along the perimeter of the resection cavity produced a significant, dose-related ( p < 0.0001). Surgical resection of the 14-day-old glioma also improvement in survival (Fig. 1b) . The dose-response curve generated from Kaplan-Meier plots was clearly eliminated most of the tumor mass and resulted in a cavity with a mean volume of 49.83 ± 3.47 mm 3 (Table 2) . nonmonotonic, however. Microsphere injections releasing 25-100 µg/site of carboplatin produced increasingly Consistent with the results obtained in the smaller (10day) tumors, eight injections of chemotherapeutic micro-robust survival rate. However, when the dose was increased further to 200 µg/site, survival was actually de-spheres exposed 41% of the larger, 14-day-old tumor margin to carboplatin. Parallel survival studies demon-creased ( p < 0.05) relative to both the surgery-alone and no resection/no treatment groups ( Fig. 1b and Table 1 ). strated that survival was significantly enhanced ( p < 0.0001) when eight microsphere injections (each sepa-Relationship Between the Spatial Distribution rated by 2 mm) were made around the larger, 14-day of Carboplatin Microsphere Injections and Survival resection cavity. In contrast, four injections (each sepa-Consistent with Experiment 1, surgical resection alone rated by 4 mm) made around the larger 14-day cavity improved survival relative to no resection/no treatment/ exposed 21% of the tumor margin to carboplatin and did no resection ( p < 0.01) (Fig. 2) . When the carboplatin not enhance survival. Together, these studies demonmicrospheres were injected along the entire perimeter of strate that, in this model, survival can be significantly the resection cavity, but placed 4 mm apart and into four enhanced when as little as 40% of the tumor margin discrete sites, no survival benefit beyond that seen with receives exposure to sustained release carboplatin. surgery alone was observed. However, microsphere in-Immunocytochemistry jections into eight sites, within 2 mm of each other, produced a robust improvement in survival, with median Quantitative analysis of neuronal numbers within the striatum following injection of carboplatin-releasing mi-and maximum survival increased 141% and 168%, respectively ( ps < 0.001). Survival was not enhanced ( ps > crospheres into a single injection site demonstrated that at relatively high local doses, carboplatin can exert a 0.1) when identical injections were made within eight sites along only one side of the resection cavity, even toxic effect on neurons (Fig. 4) . Relative to the intact, contralateral striatum, no changes in neurons were seen though the distance between the injection sites was only 1-2 mm. Together, these data demonstrate that, in this following injections of either 25 or 100 µg sustained release carboplatin. In contrast, a significant ( p < 0.01) model, sustained release chemotherapy is only effective when the resection cavity is surrounded by a relatively 32% loss of striatal neurons was seen following injection of the highest dose (200 µg) of sustained release contiguous wall of injections of chemotherapeutic microspheres.
carboplatin.
DISCUSSION

Relationship Between Diffusion of Carboplatin From Microspheres and Survival
The present experiments confirm previous observations that injections of microspheres directly into the tis-In order to evaluate the relationship between local diffusion of carboplatin from the polymer microspheres sue along the perimeter of the resection cavity significantly enhance survival (7). These studies also extend and survival, the gliomas in rats were resected at either 10 or 14 days (to produce two distinct sized tumors and those initial observations by using a greater range of doses of carboplatin to further explore the relationship resection cavities). Two parallel studies were then conducted. In one set of experiments, carboplatin diffusion between the dose of sustained release chemotherapy, the density of microsphere injections, and efficacy. These around the tumor margin was quantified and in the other experiments survival in cohorts of animals was reas-studies revealed two novel and fundamental points. First, the microsphere injection sites must be kept within sessed. In contrast, survival was significantly enhanced when eight separate implant sites (separated by 2 mm) were distributed along the perimeter of the cavity (B). Note that the dose-response curve is clearly nonmonotonic. While microspheres releasing 25-100 µg of carboplatin produced increasingly robust survival rates, increasing the dose to 200 µg/site actually decreased survival relative to surgery alone. Additional data (Fig. 4 ) demonstrated that the 200 µg/site dose of sustained release carboplatin produces a significant degeneration of neurons, suggesting that the deleterious effects on survival are secondary to neuronal toxicity. The data from these figures are also depicted in Table 1 . For comparative purposes, the same no resection/no treatment and resectiononly control groups are depicted in both (A) and (B). 2 . Survival curves demonstrating the relationship between the distribution of microsphere injections along the tumor perimeter and efficacy. Implants of carboplatin microspheres (25 µg/ site) were made into four or eight sites within the tissue surrounding a tumor resection cavity made 14 days following cell implantation. To understand how the distribution of the implant sites affects efficacy, the implants were made either contiguously around the entire perimeter (both sides) of the cavity or on only one side of the cavity. Consistent with Figure 1 , implants into four sites (independent of the distribution) did not enhance survival beyond that achieved with surgery alone. Implants into eight sites did enhance survival; this effect was only manifest when the microspheres were equally distributed along the entire perimeter of the resection cavity. Either 10 or 14 days following implantation, tumors were resected and the volumes were determined for the resulting cavity and a 2-mm strip of tumor margin immediately surrounding the cavity. Additionally, volumes were determined for carboplatin diffusion from these injection sites. Using previously published determinations of carboplatin diffusion from the microspheres used here, the percentage of the tissue surrounding the resection cavity (i.e., tumor margin) exposed to carboplatin was determined. Together with parallel survival studies, these data demonstrate that, in this model, survival is significantly enhanced when approximately 40% of the tumor margin is exposed to the chemotherapeutic. In contrast, survival was not modified when the proportion of exposed tumor margin is decreased to approximately 20%. Data are presented as mean with SEM in parentheses.
a certain distance from one another to improve survival. microspheres releasing 200 µg of carboplatin resulted in a significant degeneration of neurons proximal to the Indeed, in our model, which used an injection volume of 10 µl, no benefit was seen with any dose of sustained implant site. It seems likely, then, that the impaired survival produced by the highest dose of sustained release release carboplatin when the injections were made into separate sites that were separated by approximately 4 mm carboplatin in these studies occurred because of carboplatin-induced CNS toxicity. While the potential for from one another. In contrast, survival was markedly enhanced when identical injections were made within 2 local neuronal toxicity must be a primary concern when using injectable microspheres fabricated to deliver high mm of each other. The relative importance of the distance between the injection sites and the total dose deliv-local concentrations of chemotherapeutics, these studies also clearly demonstrate that survival can be signifi-ered over those sites is illustrated by comparing survival resulting from equivalent doses of carboplatin over vary-cantly enhanced using a wide range of carboplatin doses below those that produce neuronal cell loss. Substantial ing numbers of injection sites. For example, 50 and 100 µg of carboplatin over four sites provided a total car-increases in survival were seen using doses nearly an order of magnitude lower (25 vs. 200 µg/site) than those boplatin dose of 200 and 400 µg, respectively, but had no effect on survival beyond that obtained with surgery shown to be locally toxic.
Using atomic adsorption spectrophotometry, we pre-alone. In contrast, 25 and 50 µg of carboplatin distributed over eight sites provided the same total doses of viously demonstrated that the diffusion of carboplatin from microspheres is restricted to the tissue located carboplatin (again, a total of 200 and 400 µg) and markedly enhanced survival. within 0.5 mm from the injection site (7). Despite the natural constraints of drug diffusion in the CNS (15,16, A second point illustrated by these studies is that continued dose escalation does not necessarily provide a 21), survival in those and the present studies was still significantly enhanced. These data, therefore, suggest corresponding further improvement in survival. In fact, it can be detrimental. This was revealed in the dose-that survival can be improved even though only a portion of the tumor margin is exposed to the chemothera-response curve for efficacy with carboplatin-loaded microspheres. While microsphere injections releasing 25-peutic drug released by the microspheres. Gaining an understanding of the proportion of tissue that requires 100 µg/site of carboplatin produced increasingly robust survival rates, when the dose was increased to 200 µg/ exposure to the chemotherapeutic drug to improve survival is, accordingly, an important step towards being site, survival was worse, even compared with animals receiving no treatment/no resection. Parallel immunocy-able to achieve a drug field that encompasses enough of the tumor margin to be efficacious. To date, however, tochemical studies determined that a single injection of Figure 3 . Survival following implantation of carboplatin microspheres (25 µg/site) into the tissue surrounding a resection cavity made either 10 or 14 days following cell implantation. Implantation of carboplatin microspheres, again, significantly increased survival relative to resection only. The enhanced survival was, however, dependent on the number of implant sites, and in turn the distance between them, with four implants enhancing survival in the smaller (10-day) resection model and eight implants enhancing survival in the larger (14-day) resection model. Note that four implant sites in the larger resection model did not improve survival beyond that achieved with surgery alone. Concurrent studies (Table 2) demonstrated that approximately 40% of the tissue within 2 mm of the resection cavity was exposed to carboplatin in those animals exhibiting significantly enhanced survival. In contrast, survival was not enhanced when the amount of tissue exposed to carboplatin dropped to 20%. These experiments demonstrate that a critical portion of the tissue surrounding the resection cavity requires exposure to the chemotherapeutic to enhance efficacy. no studies have systematically or directly evaluated the animals that exhibited significantly improvements in survival. When the amount of tissue exposed to carbo-relationship between efficacy, drug diffusion, and the distribution of injection sites of sustained release poly-platin dropped to approximately 20%, as occurred when the injection sites where 4 mm apart from each other, mers. By varying the time of surgical resection following the initial implantation, we produced surgical cavi-survival was not enhanced. Together, these data clearly demonstrate the need to maintain a close juxtaposition-ties of different sizes and then used different numbers of injections around those cavities to systematically vary ing of injection sites in order to enhance survival. On the one hand, these data hold promise for the use of the distance between the injection sites while maintaining the total dose of chemotherapy constant. While sur-chemotherapeutic microspheres, in that complete coverage of the peritumoral area in humans might not be re-vival was enhanced when the distance between injection sites was maintained at 2 mm, the sustained release mi-quired in order to improve survival. On the other hand, if the close positioning of the microspheres required in crospheres were ineffective when the distance was increased to 4 mm. Using previously published measures the present model proves predictive of human glioma, then adequate drug diffusion over distances of centime-of carboplatin diffusion from the identical microspheres used in the current studies (7), it was estimated that ap-ters, rather than millimeters, might require an impractical number of microsphere injections. Answers to these proximately 40% of the tissue within a 2-mm strip surrounding the cavity received exposure to carboplatin in questions will require further study, likely in larger-together, these experiments demonstrate that enhanced survival is dependent on both the distance between the chemotherapeutic microsphere injections and the distribution of those injections. They also caution that the survival benefits afforded by local delivery using chemotherapeutic microspheres, or other local delivery systems, may not be realized in instances where major portions of the tumor periphery are not accessible for injection. In summary, the data from these studies detail several new findings and principles regarding the use of sustained release chemotherapy for treating glioma. Given the typically constrained drug diffusion within the brain, the use of injectable microspheres implanted into multiple peritumoral sites might provide one means of improving the limited spatial drug diffusion from the implantation site. The small injectable nature of microspheres also provides considerable flexibility relative to larger implantable delivery systems (9, 23) . However, the current experiments caution that a number of parameters pro- 
